Furthermore, RSV showed antitumor effects in mice, affecting tumor proliferation in a dose- and time-dependent manner; similarly, survivin expression in SPC-A-1/CDDP cells decreased after RSV treatment (Zhao et al., 2010). Here, BIRC5 is linked to neoplasm.